Literature DB >> 26313901

Selenium and the thyroid.

Josef Köhrle1.   

Abstract

PURPOSE OF REVIEW: This article provides an update on the role of the essential trace element selenium and its interaction with the other trace elements iodine and iron that together contribute to adequate thyroid hormone status. Synthesis, secretion, metabolism and action of thyroid hormone in target tissues depend on a balanced nutritional availability or supplementation of these elements. Selenium status is altered in benign and malignant thyroid diseases and various selenium compounds have been used to prevent or treat widespread diseases such as goiter, autoimmune thyroid disease or thyroid cancer. RECENT
FINDINGS: Several studies, most with still too low numbers of cases, indicate that selenium administration in both autoimmune thyroiditis (Hashimoto thyroiditis) and mild Graves' disease improves clinical scores and well-being of patients and reduces thyroperoxidase antibody titers. However, published results are still conflicting depending on basal selenium status, dose, time and form of selenium used for intervention. Evidence for sex-specific selenium action, lack of beneficial effects in pregnancy and contribution of genetic polymorphisms (selenoprotein S) has been presented.
SUMMARY: Adequate nutritional supply of selenium that saturates expression of circulating selenoprotein P, together with optimal iodine and iron intake, is required for a healthy and functional thyroid during development, adolescence, adulthood and aging.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26313901     DOI: 10.1097/MED.0000000000000190

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  28 in total

1.  Selenium in the Treatment of Thyroid Diseases: An Element in Search of the Relevant Indications?

Authors:  Laszlo Hegedüs; Steen J Bonnema; Kristian H Winther
Journal:  Eur Thyroid J       Date:  2016-08-06

2.  Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.

Authors:  M Leo; L Bartalena; G Rotondo Dottore; E Piantanida; P Premoli; I Ionni; M Di Cera; E Masiello; L Sassi; M L Tanda; F Latrofa; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-10-12       Impact factor: 4.256

3.  Influence of short-term selenium supplementation on the natural course of Hashimoto's thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial.

Authors:  D Esposito; M Rotondi; G Accardo; G Vallone; G Conzo; G Docimo; F Selvaggi; C Cappelli; L Chiovato; D Giugliano; D Pasquali
Journal:  J Endocrinol Invest       Date:  2016-08-29       Impact factor: 4.256

4.  Levothyroxine monotherapy versus levothyroxine and selenium combination therapy in chronic lymphocytic thyroiditis.

Authors:  L Yu; L Zhou; E Xu; Y Bi; X Hu; X Pei; G Jin
Journal:  J Endocrinol Invest       Date:  2017-05-22       Impact factor: 4.256

Review 5.  Current and Emerging Treatment Strategies for Graves' Orbitopathy.

Authors:  Natalia Genere; Marius N Stan
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

6.  Variable Effects of Dietary Selenium in Mice That Spontaneously Develop a Spectrum of Thyroid Autoantibodies.

Authors:  Sandra M McLachlan; Holly Aliesky; Bianca Banuelos; Shane S Que Hee; Basil Rapoport
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

7.  Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.

Authors:  Mohamed S Abdelfattah; Sherif E A Badr; Sally A Lotfy; Gouda H Attia; Ahmed M Aref; Ahmed E Abdel Moneim; Rami B Kassab
Journal:  Neurotox Res       Date:  2019-07-22       Impact factor: 3.911

8.  Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts.

Authors:  Rosaria M Ruggeri; Angela D'Ascola; Teresa M Vicchio; Salvatore Campo; Fiorenza Gianì; Salvatore Giovinazzo; Francesco Frasca; Salvatore Cannavò; Alfredo Campennì; Francesco Trimarchi
Journal:  Endocrine       Date:  2019-12-30       Impact factor: 3.633

9.  A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto's Thyroiditis.

Authors:  Kristian Hillert Winther; Enrico Papini; Roberto Attanasio; Roberto Negro; Laszlo Hegedüs
Journal:  Eur Thyroid J       Date:  2020-01-14

10.  A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Graves' Hyperthyroidism and Graves' Orbitopathy.

Authors:  Roberto Negro; Laszlo Hegedüs; Roberto Attanasio; Enrico Papini; Kristian H Winther
Journal:  Eur Thyroid J       Date:  2018-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.